EPS for Apollo Endosurgery, Inc. (APEN) Expected At $-0.35 as of March, 7

Investors wait Apollo Endosurgery, Inc. (NASDAQ:APEN)’s quarterly earnings on March, 7., according to Zacks. earnings per share of $-0.35 is 16.67 % up from 2018’s $-0.42 EPS. Last quarter $-0.45 earnings per share was reported. Analysts predicts -22.22 % EPS growth this quarter. APEN is reaching $3.76 during the last trading session, after increased 5.32%.Currently Apollo Endosurgery, Inc. is downtrending after 7.09% change in last February 11, 2018. APEN has 23,793 shares volume. APEN underperformed by 7.09% the S&P 500.

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for the treatment of obesity.The firm is valued at $82.32 million. The firm offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope.Currently it has negative earnings. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries.

For more Apollo Endosurgery, Inc. (NASDAQ:APEN) news announced recently go to: Businesswire.com, Businesswire.com, Businesswire.com, Bizjournals.com or Businesswire.com. The titles are as follows: “Apollo Endosurgery Completes Merger with Lpath; Initiates Trading on NASDAQ as ‘APEN’ – Business Wire” announced on December 29, 2016, “Apollo Endosurgery Receives FDA Clearance for OverStitchâ„¢ Sx Endoscopic Suturing System – Business Wire” on November 27, 2017, “Apollo Endosurgery Announces Presentation of Mortality and Inpatient Costs of Revisional Bariatric Surgery – Business Wire” with a publish date: June 04, 2018, “Austin medical device maker goes public after completing reverse merger – Austin Business Journal” and the last “Apollo Endosurgery Announces First Commercial Shipment of the OverStitchâ„¢ Sx Endoscopic Suturing System – Business Wire” with publication date: November 27, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.